Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2025
상품코드:1825767
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
인간면역결핍바이러스(HIV) 진단 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 10.1%로 68억 8,000만 달러로 성장할 것입니다. 예측 기간의 성장은 공중보건 캠페인 및 인식 개선 활동, 형평성과 포용성에 대한 강조, 의료 환경에서의 일상적인 검사, 커뮤니티 주도 및 동료 주도적 접근 방식, 자가 검사의 확대 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 검사 기술의 발전, 표적화된 검사 전략의 중요성, 지역사회 기반 검사 및 아웃리치, 공정성과 포용성의 중요성, 정책 및 자금의 우선순위 등을 꼽을 수 있습니다.
향후 5년간 10.1%의 성장률 전망은 지난번 예측보다 0.9% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 한국이나 독일에서 공급되는 HIV 신속 검사 키트와 바이러스 양 측정 시스템의 비용을 높이고, 검진 지연을 악화시키며, 공중 보건 프로그램 비용을 증가시켜 미국 환자들에게 부담을 줄 가능성이 높습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
예상되는 헌혈의 증가는 당분간 HIV 진단 시장의 확대를 촉진할 것입니다. 헌혈은 채혈을 통한 자발적 헌혈 행위가 특징이며, 의료 기술의 발전, 지역사회 참여 증가, 기증자 모집 및 유지 전략 강화로 인해 증가 추세를 보이고 있습니다. 이러한 헌혈의 급증은 HIV 검사에 사용할 수 있는 샘플 풀을 늘리는 데 도움이 됩니다. 그 결과, 혈액 샘플의 가용성이 높아짐에 따라 HIV 항체 또는 항원에 대한 보다 종합적인 스크리닝이 용이해져 HIV 진단의 정확성과 신뢰성이 향상될 수 있습니다. 예를 들어, 영국 정부 기관인 NHS Blood and Transplant는 신규 헌혈자 수가 2022-2023년 11만 9,016명에서 2023-2024년 11만 9,371명으로 증가할 것으로 보고하고 있으며, 헌혈자 수 증가가 HIV 진단 시장의 성장을 촉진하는 데 있어 매우 중요한 역할을 할 것으로 예상하고 있습니다. 중요한 역할을 하고 있음을 강조하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 인간면역결핍바이러스(HIV) 진단 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 인간면역결핍바이러스(HIV) 진단 시장 : 성장률 분석
세계의 인간면역결핍바이러스(HIV) 진단 시장 실적 : 규모와 성장, 2019-2024
세계의 인간면역결핍바이러스(HIV) 진단 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 인간면역결핍바이러스(HIV) 진단 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 인간면역결핍바이러스(HIV) 진단 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
소모품
기기
소프트웨어와 서비스
세계의 인간면역결핍바이러스(HIV) 진단 시장 모드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
셀프 테스트
실험실 기반
세계의 인간면역결핍바이러스(HIV) 진단 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
진단 검사실
병원
조사기관
세계의 인간면역결핍바이러스(HIV) 진단 시장 : 하위 세분화 소모품(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
검사 키트(신속 HIV 검사 키트, ELISA 검사 키트)
시약과 화학제품
샘플 채취 기구(채혈관, 란셋)
테스트 스트립
제어 및 교정 키트
일회용 장갑과 안전 장비
세계의 인간면역결핍바이러스(HIV) 진단 시장 : 하위 세분화 기기 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
HIV 진단 분석기(자동 면역측정 분석기)
HIV 바이러스 양검사 장비
CD4 카운트 분석기
POC(Point of Care) HIV 진단 장비
분자진단 기기(PCR 장비)
전기화학적 및 광학적 HIV 검출 장비
세계의 인간면역결핍바이러스(HIV) 진단 시장 : 하위 세분화 소프트웨어(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
HIV 진단 데이터 관리 소프트웨어
전자건강기록(EHR) 통합 소프트웨어
HIV 검사 결과 해석 소프트웨어
검사 정보 관리 시스템(LIMS)
환자 모니터링 및 추적 소프트웨어
클라우드 기반 HIV 진단 보고 툴
세계의 인간면역결핍바이러스(HIV) 진단 시장 : 하위 세분화 서비스(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
진단 검사 서비스
HIV 검사 지원 서비스(상담, 교육)
진단 실험실 서비스
원격의료와 원격 HIV 검사 서비스
HIV 진단 검사 임상시험 서비스
HIV 검사를 위한 데이터 분석·해석 서비스
제7장 지역별·국가별 분석
세계의 인간면역결핍바이러스(HIV) 진단 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 인간면역결핍바이러스(HIV) 진단 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
인간면역결핍바이러스(HIV) 진단 시장 : 경쟁 구도
인간면역결핍바이러스(HIV) 진단 시장 : 기업 개요
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Hologic Inc.
bioMerieux SA
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Bio-Techne Corporation
Alere Inc.
Cepheid Inc.
OraSure Technologies Inc.
Advanced Instruments Inc.
BBI Solutions
Chembio Diagnostic Systems Inc.
BioLytical Laboratories Inc.
Avioq Inc.
Advanced Biochemicals Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
인간면역결핍바이러스(HIV) 진단 시장 2029 : 새로운 기회를 제공하는 국가
인간면역결핍바이러스(HIV) 진단 시장 2029 : 새로운 기회를 제공하는 부문
인간면역결핍바이러스(HIV) 진단 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Human immunodeficiency virus (HIV) diagnosis encompasses the process of determining whether an individual has contracted the human immunodeficiency virus, which leads to acquired immunodeficiency syndrome (AIDS). This diagnostic procedure involves testing for the presence of HIV antibodies, antigens, or viral genetic material in bodily fluids such as blood, saliva, or other relevant specimens.
The primary products utilized in HIV diagnosis include consumables, instruments, and software and services. Consumables refer to materials or supplies that are used up during diagnostic procedures, and they can be deployed in various formats including self-tests and lab-based assays. These products find application across diverse end users such as diagnostic laboratories, hospitals, and research institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The HIV diagnosis market research report is one of a series of new reports from The Business Research Company that provides HIV diagnosis market statistics, including HIV diagnosis industry global market size, regional shares, competitors with a HIV diagnosis market share, detailed HIV diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the HIV diagnosis industry. This HIV diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The human immunodeficiency virus (hiv) diagnosis market size has grown rapidly in recent years. It will grow from $4.2 billion in 2024 to $4.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to expansion of voluntary counseling and testing, development of HIV antibody tests, emergence of the HIV/AIDS epidemic, and community-led and peer-led initiatives.
The human immunodeficiency virus (hiv) diagnosis market size is expected to see rapid growth in the next few years. It will grow to $6.88 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to public health campaigns and awareness initiatives, focus on equity and inclusivity, routine testing in healthcare settings, community-led and peer-led approaches, and expansion of self-testing. Major trends in the forecast period include advancements in testing technologies, focus on targeted testing strategies, community-based testing and outreach, emphasis on equity and inclusivity, and policy and funding priorities.
The forecast of 10.1% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of rapid HIV test kits and viral load assay systems sourced from South Korea and Germany, exacerbating screening delays and increasing public health program costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in blood donation is poised to drive the expansion of the HIV diagnosis market in the foreseeable future. Blood donation, characterized by the voluntary act of giving blood through phlebotomy, has seen a rise attributed to advancements in medical technology, heightened community engagement, and enhanced donor recruitment and retention strategies. This surge in blood donation results in a larger pool of samples available for HIV testing. Consequently, the heightened availability of blood samples facilitates more comprehensive screening for HIV antibodies or antigens, thereby improving the accuracy and reliability of HIV diagnosis. For example, NHS Blood and Transplant, a UK-based government agency, reported an increase in new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024, underscoring the pivotal role of rising blood donation in propelling the growth of the HIV diagnosis market.
Major players in the HIV diagnosis market are actively developing chip-based real-time PCR test solutions tailored for HIV, aimed at enhancing accuracy, reducing turnaround time, and improving accessibility. Chip-based real-time PCR test solutions utilize microfluidic chips or small integrated circuits to conduct real-time polymerase chain reaction (PCR) tests for HIV detection. For instance, in August 2022, Molbio Diagnostics, an India-based molecular diagnostics manufacturer, unveiled the Truenat HIV-1 test, a chip-based real-time PCR test designed for the quantitative detection and diagnosis of human immunodeficiency virus type 1 (HIV-1) in whole blood and plasma. Leveraging Taqman chemistry, this test boasts high primer sensitivity and specificity, requiring minimal sample volume and featuring an intelligent chip with lot-specific data for result quantification, along with contamination- and evaporation-resistant design elements.
In May 2022, Roche, a Switzerland-based biopharmaceutical and diagnostic company, forged a partnership with the Global Fund, aiming to bolster diagnostic infrastructure in low- and middle-income countries. This collaboration seeks to facilitate improved diagnosis and treatment of HIV and tuberculosis within the framework of Roche's Global Access Program and the Global Fund's broader initiatives targeting HIV, tuberculosis, and malaria globally. The Global Fund, an international financing and partnership organization headquartered in Switzerland, focuses on providing grants to strengthen health systems addressing HIV/AIDS.
Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.
North America was the largest region in the HIV diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the human immunodeficiency virus (HIV) diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The human immunodeficiency virus (HIV) diagnosis market consists of revenues earned by entities by providing services such as HIV testing, pre-test counseling, post-test counseling, laboratory-based testing, point-of-care testing, partner notification services, and linkage to care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The human immunodeficiency virus (HIV) diagnosis market also includes sales of diagnostic kits, testing equipment such as enzyme-linked immunosorbent assay (ELISA) readers and polymerase chain reaction (PCR) machines, point-of-care testing devices, laboratory equipment such as centrifuges and microscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on human immunodeficiency virus (hiv) diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for human immunodeficiency virus (hiv) diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The human immunodeficiency virus (hiv) diagnosis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Consumables; Instruments; Software And Services
2) By Mode: Self-Test; Lab-Based
3) By End User: Diagnostic Laboratories; Hospitals; Research Institutions
Subsegments:
1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits); Reagents And Chemicals; Sample Collection Devices (Blood Collection Tubes, Lancets); Test Strips; Control And Calibration Kits; Disposable Gloves And Safety Equipment
2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers); Hiv Viral Load Testing Equipment; Cd4 Count Analyzers; Point-Of-Care Hiv Diagnostic Devices; Molecular Diagnostic Instruments ( Pcr Machines); Electrochemical And Optical Hiv Detection Instruments
3) By Software: Hiv Diagnosis Data Management Software; Electronic Health Record (Ehr) Integration Software; Hiv Test Result Interpretation Software; Laboratory Information Management Systems (Lims); Patient Monitoring And Tracking Software; Cloud-Based Hiv Diagnostic Reporting Tools
4) By Services: Diagnostic Testing Services; Hiv Testing Support Services ( Counseling, Education); Diagnostic Lab Services; Telemedicine And Remote Hiv Testing Services; Clinical Trial Services For Hiv Diagnostic Tests; Data Analytics And Interpretation Services For Hiv Testing
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Human Immunodeficiency Virus (HIV) Diagnosis Market Characteristics
3. Human Immunodeficiency Virus (HIV) Diagnosis Market Trends And Strategies
4. Human Immunodeficiency Virus (HIV) Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Human Immunodeficiency Virus (HIV) Diagnosis Growth Analysis And Strategic Analysis Framework
5.1. Global Human Immunodeficiency Virus (HIV) Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Growth Rate Analysis
5.4. Global Human Immunodeficiency Virus (HIV) Diagnosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Human Immunodeficiency Virus (HIV) Diagnosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Human Immunodeficiency Virus (HIV) Diagnosis Total Addressable Market (TAM)
6. Human Immunodeficiency Virus (HIV) Diagnosis Market Segmentation
6.1. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumables
Instruments
Software And Services
6.2. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Self-Test
Lab-Based
6.3. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Laboratories
Hospitals
Research Institutions
6.4. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.5. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
HIV Diagnostic Analyzers (Automated Immunoassay Analyzers)
HIV Viral Load Testing Equipment
CD4 Count Analyzers
Point-Of-Care HIV Diagnostic Devices
Molecular Diagnostic Instruments (PCR Machines)
Electrochemical And Optical HIV Detection Instruments
6.6. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
HIV Diagnosis Data Management Software
Electronic Health Record (EHR) Integration Software
HIV Test Result Interpretation Software
Laboratory Information Management Systems (LIMS)
Patient Monitoring And Tracking Software
Cloud-Based HIV Diagnostic Reporting Tools
6.7. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Testing Services
HIV Testing Support Services (Counseling, Education)
Diagnostic Lab Services
Telemedicine And Remote HIV Testing Services
Clinical Trial Services For HIV Diagnostic Tests
Data Analytics And Interpretation Services For HIV Testing
7. Human Immunodeficiency Virus (HIV) Diagnosis Market Regional And Country Analysis
7.1. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market
8.1. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Human Immunodeficiency Virus (HIV) Diagnosis Market
9.1. China Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
9.2. China Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Human Immunodeficiency Virus (HIV) Diagnosis Market
10.1. India Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market
11.1. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
11.2. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market
12.1. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market
13.1. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market
14.1. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
14.2. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market
15.1. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
15.2. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Human Immunodeficiency Virus (HIV) Diagnosis Market
16.1. UK Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market
17.1. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Human Immunodeficiency Virus (HIV) Diagnosis Market
18.1. France Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market
19.1. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market
20.1. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market
21.1. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
21.2. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market
22.1. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Human Immunodeficiency Virus (HIV) Diagnosis Market
23.1. North America Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
23.2. North America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Human Immunodeficiency Virus (HIV) Diagnosis Market
24.1. USA Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
24.2. USA Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market
25.1. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
25.2. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Human Immunodeficiency Virus (HIV) Diagnosis Market
26.1. South America Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
26.2. South America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market
27.1. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market
28.1. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
28.2. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market
29.1. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
29.2. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Landscape And Company Profiles
30.1. Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Landscape
30.2. Human Immunodeficiency Virus (HIV) Diagnosis Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
31. Human Immunodeficiency Virus (HIV) Diagnosis Market Other Major And Innovative Companies
31.1. Hologic Inc.
31.2. bioMerieux SA
31.3. Beckman Coulter Inc.
31.4. Bio-Rad Laboratories Inc.
31.5. QIAGEN N.V.
31.6. Bio-Techne Corporation
31.7. Alere Inc.
31.8. Cepheid Inc.
31.9. OraSure Technologies Inc.
31.10. Advanced Instruments Inc.
31.11. BBI Solutions
31.12. Chembio Diagnostic Systems Inc.
31.13. BioLytical Laboratories Inc.
31.14. Avioq Inc.
31.15. Advanced Biochemicals Ltd.
32. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Human Immunodeficiency Virus (HIV) Diagnosis Market
34. Recent Developments In The Human Immunodeficiency Virus (HIV) Diagnosis Market
35. Human Immunodeficiency Virus (HIV) Diagnosis Market High Potential Countries, Segments and Strategies
35.1 Human Immunodeficiency Virus (HIV) Diagnosis Market In 2029 - Countries Offering Most New Opportunities
35.2 Human Immunodeficiency Virus (HIV) Diagnosis Market In 2029 - Segments Offering Most New Opportunities
35.3 Human Immunodeficiency Virus (HIV) Diagnosis Market In 2029 - Growth Strategies
